Decreased the fasting blood glucose level, improved oral glucose tolerance, alleviated insulin resistance; activated IRS1, PI3K, and GLUT4, inhibited JNK1/2; regulated the IRS1/PI3K and JNK signaling. The gene discussed is SLC2A4; the disease is Insulin resistance.